Stocks rebounded Tuesday from last week's sell-off as investors were cheered by positive earnings reports. The Dow Jones Industrial Average (DJINDICES:^DJI) and the S&P 500 (SNPINDEX:^GSPC) both gained more than 2%.

Today's stock market

Index Percentage Change Point Change
Dow 2.17% 547.87
S&P 500 2.15% 59.13

Data source: Yahoo! Finance.

Investors snapped up technology shares that had taken a beating recently, with the First Trust Dow Jones Internet ETF (NYSEMKT:FDN) surging 3.4%. Healthcare stocks also had big gains; the Vanguard Health Care ETF (NYSEMKT:VHT) closed up 3.1%. 

As for individual stocks, Morgan Stanley (NYSE:MS) blew away third-quarter expectations and Johnson & Johnson (NYSE:JNJ) also reported strong results.

Image source: Getty Images.

Morgan Stanley profits from increasing IPO activity

Shares of Morgan Stanley rose 5.7% after the bank reported third-quarter results that beat expectations by a wide margin. Revenue grew 7.3% to $9.87 billion and earnings per share jumped 26% to $1.17. Analysts were expecting earnings of $1.02 per share on revenue of $9.55 billion.

Strong activity in the initial public offering (IPO) market boosted Morgan Stanley's investment banking unit, which had a 12.6% increase in revenue and a 26% gain in pre-tax income. The company's wealth management segment delivered a 6.7% jump in pre-tax income on 4.2% revenue growth. Return on common equity was 11.5% in the traditionally weaker summer quarter, compared with 9.6% in the period a year ago.

CEO James Gorman was questioned on the conference call about the lagging stock price, which is down 11% this year despite some outstanding results. Gorman admitted he was perplexed about it, but said:

So what I care about, frankly, is the long-term positioning of the firm. This firm is positioned for resilience through cycles, that's exactly what we demonstrate in this quarter. To deliver $9.9 billion of revenue in a summer quarter that was unheard of a couple of years ago.

Morgan Stanley's stock may have also gotten a boost on news today that the bank may be an underwriter of one of next year's biggest IPOs. The Wall Street Journal (subscription required) reported that Morgan Stanley delivered a valuation proposal to Uber, a move that often happens before a bank is hired to underwrite the offering. 

Johnson & Johnson reports healthy sales gains

Healthcare giant Johnson & Johnson reported strong third-quarter results, and shares rose 2%. Revenue grew 3.6% to $20.3 billion, beating the $20.05 billion analyst consensus. Excluding currency losses and the effects of acquisitions and divestitures, worldwide sales grew 6.1%. Adjusted earnings per share increased 7.9% to $2.05, above expectations for EPS of $2.03.

Sales in the U.S grew 3.6% and international sales were up 7.5%, excluding currency effects. As it has in recent quarters, sales gains by the pharmaceutical segment -- 8.2% on an operational basis -- led the company. Consumer sales were up 4.9%, which is a big improvement from recent quarters, and medical device sales lagged with 1.7% growth.

Looking ahead, Johnson & Johnson boosted its guidance for operational sales gains for the year to 5.5%-6%, up from 4.5%-5.5% previously. Adjusted EPS guidance was raised 4% at the midpoint to a range of $7.98 to $8.03.

"We are pleased with our strong third-quarter performance, which reflects continued above-market growth in our Pharmaceutical business, accelerating sales momentum in our Consumer business and consistent progress in our Medical Devices business," said CEO Alex Gorsky in the press release.

Johnson & Johnson is among the first of the big healthcare stocks to report this earnings season, and the encouraging results helped boost the whole sector today.

Offer from The Motley Fool: The 10 best stocks to buy now
Motley Fool co-founders Tom and David Gardner have spent more than a decade beating the market. In fact, the newsletter they run, Motley Fool Stock Advisor, has tripled the S&P 500!*

Tom and David just revealed their ten top stock picks for investors to buy right now.

Click here to get access to the full list!

*Stock Advisor returns as of Aug. 6, 2018.

Jim Crumly owns shares of Johnson & Johnson. The Motley Fool owns shares of Johnson & Johnson and has the following options: short October 2018 $135 calls on Johnson & Johnson. The Motley Fool has a disclosure policy.